
NYSEHealthcareMedical - Diagnostics & Research
أحدث البيانات المتاحة
219.87 US$
+2.41 US$ · +1.11%
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
الإغلاق السابق
219.87 US$
+2.41 US$ · +1.11%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
نطاق اليوم
السعر الحالي 219.87 US$
نطاق 52 أسبوعًا
السعر الحالي 219.87 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
شراء
تقييم
69
أقل من القيمة
المشاعر
68
صعودي
المخاطر
30
مخاطر متوسطة
الزخم
48
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
نطاق اليوم
السعر الحالي 219.87 US$
نطاق 52 أسبوعًا
السعر الحالي 219.87 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 24.57 مليار USD | 23.88 مليار USD | 23.89 مليار USD | 26.64 مليار USD | 29.45 مليار USD |
| تكلفة البضاعة المباعة | 9.6 مليار USD | 9.67 مليار USD | 9.86 مليار USD | 10.46 مليار USD | 11.5 مليار USD |
| الربح الإجمالي | 14.97 مليار USD | 14.21 مليار USD | 14.03 مليار USD | 16.19 مليار USD | 17.95 مليار USD |
| البحث والتطوير | 1.6 مليار USD | 1.58 مليار USD | 1.5 مليار USD | 1.53 مليار USD | 1.74 مليار USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 8.24 مليار USD | 7.44 مليار USD | 7.25 مليار USD | 7.12 مليار USD | 8.16 مليار USD |
| نفقات التشغيل | 9.83 مليار USD | 9.02 مليار USD | 8.76 مليار USD | 8.65 مليار USD | 9.9 مليار USD |
| دخل الفوائد | 30 مليون USD | 117 مليون USD | 303 مليون USD | 41 مليون USD | 11 مليون USD |
| مصاريف الفوائد | 265 مليون USD | 278 مليون USD | 289 مليون USD | 207 مليون USD | 241 مليون USD |
| الاستهلاك والإطفاء | 2.45 مليار USD | 2.35 مليار USD | 2.17 مليار USD | 2.13 مليار USD | 2.17 مليار USD |
| الدخل التشغيلي | 5.14 مليار USD | 5.18 مليار USD | 5.28 مليار USD | 7.54 مليار USD | 8.05 مليار USD |
| صافي الدخل | 3.61 مليار USD | 3.9 مليار USD | 4.76 مليار USD | 7.21 مليار USD | 6.43 مليار USD |
تم تحديث حقائق الشركة 10 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
230.31 US$
ارتفاع محتمل بنسبة 4.75%سجل الأسعار غير متاح
عالي: 250 US$متوسط: 230.31 US$قليل: 195 US$| الإجراء | تاريخ النفاذ | تفاصيل | تاريخ التسجيل | تاريخ الدفع |
|---|---|---|---|---|
تقسيم الأسهم | 2 أكتوبر 2023 | 141:125 | — | — |
تقسيم الأسهم | 5 يوليو 2016 | 1,319:1,000 | — | — |
تقسيم الأسهم | 14 يونيو 2010 | 2:1 | — | — |
تقسيم الأسهم | 21 مايو 2004 | 2:1 | — | — |
تقسيم الأسهم | 1 يونيو 1998 | 2:1 | — | — |
تقسيم الأسهم | 23 يناير 1995 | 2:1 | — | — |
ساري 2 أكتوبر 2023
141:125
ساري 5 يوليو 2016
1,319:1,000
ساري 14 يونيو 2010
2:1
ساري 21 مايو 2004
2:1
ساري 1 يونيو 1998
2:1
ساري 23 يناير 1995
2:1
صناديق متداولة تفصح عن تعرضها لهذا السهم.
State Street SPDR S&P 500 ETF1557.T262.9 مليار0.20%129.34 ترليون JPY0.09%122,850 JP¥+0.12%
Vanguard Morningstar Total Stock Market ETFVTI4.32 مليار0.18%2.3 ترليون USD0.03%381.94 US$+0.63%
Vanguard S&P 500 ETFVOO3.57 مليار0.20%1.8 ترليون USD0.03%715.59 US$+0.61%
iShares Core S&P 500 ETFIVV1.81 مليار0.20%892.79 مليار USD0.03%781.97 US$+0.60%
State Street SPDR S&P 500 ETFSPY1.66 مليار0.20%817.2 مليار USD0.09%778.57 US$+0.60%
Vanguard Morningstar Value ETFVTV1.3 مليار0.50%262.4 مليار USD0.03%220.59 US$+0.44%
State Street Health Care Select Sector SPDR ETFXLV968.92 مليون2.23%43.54 مليار USD0.08%170.81 US$+1.58%
Vanguard Dividend Appreciation ETFVIG761.5 مليون0.57%132.4 مليار USD0.04%239.05 US$+0.70%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLV
Vanguard Dividend Appreciation ETFVIGالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.